The Cell Cycle is a highly regulated and orchestrated process through which eukaryotic cells undergo growth, replication, and division. Comprising distinct phases, including G1 (cell growth), S (DNA synthesis), G2 (preparation for division), and M (mitosis or meiosis), the cell cycle ensures the faithful duplication and distribution of genetic material to daughter cells. Key checkpoints, controlled by regulatory proteins like cyclins and cyclin-dependent kinases (CDKs), govern transitions between these phases, ensuring accurate progression and detecting DNA damage or abnormalities. The G1 checkpoint, in particular, plays a pivotal role in determining whether a cell proceeds to division or enters a quiescent state (G0). Proper cell cycle regulation is crucial for normal cellular function and tissue homeostasis, preventing uncontrolled proliferation or genomic instability. Dysregulation of the cell cycle is a hallmark of cancer, where cells evade checkpoints and exhibit uncontrolled growth. Understanding the intricacies of the cell cycle is integral to both basic biology and therapeutic strategies, with targeted interventions seeking to modulate cell cycle progression for the treatment of various diseases, including cancer. Ongoing research continues to unveil the complexities of cell cycle control, offering insights into cellular behavior and potential avenues for medical interventions.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy